Monday, February 18, 2019

Parkinsons Disease Essay -- Disorders Illnesses Papers

Parkinsons DiseaseIn 1817, James Parkinson published his famous treatise An Essay on the Shaking Palsy, describing the symptoms which outright collectively bear his name. Although many scientists before his time had described diverse aspects of motor dysfunction (ataxia, paralysis, tremor) Parkinson was the first to collect them into a common syndrome ace which he believed formed a distinctive condition. His sixty-six page bear witness contained five chapters describing symptoms, differential diagnoses, causality, possible treatments, and prospects for future study. What is most intriguing concerning Parkinsons analysis (besides its consistent accuracy) is the fact that his clinical observations and inferences were made by observation the movements of six elderly males at a distance along the streets of London. The symptoms seen in Parkinsons Disease (PD) ar of two distinct types (1) a retroversion of normal actions and movements coupled with (2) the appearance of abnormal-type behaviors. Positive symptoms ar those behaviors not commonly seen in normal people since they occur often in patients with PD, they are thought to be mechanistically inhibited by normal physiologic systems. However, when these systems degenerate or become damaged, they are released and abnormal behavior is the result. The master(prenominal) abnormalities seen in Parkinsonian patients are resting tremor, muscular rigidity, and anesthesia. Resting tremors occur while the patient is placid the symptoms disappear during activity or when the patient is asleep. They most often pass over alternating movements of the limbs, hands and head for instance, one diagnostic tremor cognize as pill-rolling, consists of repetitive rolling motions of the forefinger past the... ... neurotoxin, 1-methyl--1,2,3,6-tetrahydro-pyridine. Life Science, 1985, 362503-2508. Neurochemistry. 1986, 46 1501-1507. 8. Schapira, A. H. V. et. al. Mitochondrial complex I deficiency in Parkinsons disease. J. of Neurochemistry. 1990, 54 823-827. 9. Wachtel, H. Antiparkinsonian dopamine agonists a review of the pharmacokinetics and neuro materia medica in animals and humans. J. of Neural Transmission. 1991, 3 151-201. 10. Mercuri, N. B. et. al. Physiology and pharmacological medicine of dopamine D2-receptors their implications in dopamine--substitute therapy for Parkinsons disease. Neurology. 1989, 391106-1108. 11. Riederer, P. Konradi, C. Youdim, M. B. H. The role of MAO in dopaminergic transmission. pp. 149-153. In M. B. Streifler, ed. Advances in Neurology, Vol. 53 Parkinsons Disease Anatomy, Pathology, and Therapy. New York, antedate Press, 1990. Parkinsons Disease Essay -- Disorders Illnesses PapersParkinsons DiseaseIn 1817, James Parkinson published his famous treatise An Essay on the Shaking Palsy, describing the symptoms which today collectively bear his name. Although many scientists before his time had described dissimilar aspects of motor dysfunction (ataxia, p aralysis, tremor) Parkinson was the first to collect them into a common syndrome one which he believed formed a distinctive condition. His sixty-six page turn up contained five chapters describing symptoms, differential diagnoses, causality, possible treatments, and prospects for future study. What is most intriguing concerning Parkinsons analysis (besides its consistent accuracy) is the fact that his clinical observations and inferences were made by notice the movements of six elderly males at a distance along the streets of London. The symptoms seen in Parkinsons Disease (PD) are of two distinct types (1) a decadency of normal actions and movements coupled with (2) the appearance of abnormal-type behaviors. Positive symptoms are those behaviors not normally seen in normal people since they occur often in patients with PD, they are thought to be mechanistically inhibited by normal physiological systems. However, when these systems degenerate or become damaged, they are released and abnormal behavior is the result. The briny abnormalities seen in Parkinsonian patients are resting tremor, muscular rigidity, and anesthesia. Resting tremors occur while the patient is smooth the symptoms disappear during activity or when the patient is asleep. They most often cut through alternating movements of the limbs, hands and head for instance, one diagnostic tremor cognize as pill-rolling, consists of repetitive rolling motions of the forefinger past the... ... neurotoxin, 1-methyl--1,2,3,6-tetrahydro-pyridine. Life Science, 1985, 362503-2508. Neurochemistry. 1986, 46 1501-1507. 8. Schapira, A. H. V. et. al. Mitochondrial complex I deficiency in Parkinsons disease. J. of Neurochemistry. 1990, 54 823-827. 9. Wachtel, H. Antiparkinsonian dopamine agonists a review of the pharmacokinetics and neuropharmacology in animals and humans. J. of Neural Transmission. 1991, 3 151-201. 10. Mercuri, N. B. et. al. Physiology and pharmacology of dopamine D2-receptors their implicat ions in dopamine--substitute therapy for Parkinsons disease. Neurology. 1989, 391106-1108. 11. Riederer, P. Konradi, C. Youdim, M. B. H. The role of MAO in dopaminergic transmission. pp. 149-153. In M. B. Streifler, ed. Advances in Neurology, Vol. 53 Parkinsons Disease Anatomy, Pathology, and Therapy. New York, antedate Press, 1990.

No comments:

Post a Comment